The veil of secrecy is lifted...
Everyone recognizes the potential of drugs targeting epigenetic pathways. Including the large drug developers and innovative biotechs who are working with us to put together this meeting
Amidst so many excellent academic-focussed meetings we are offering a completely different epigenetic conference. We are bringing together the leading commercial players in this field offering you the opportunity to find out more about the research that until now has taken place behind closed doors. This meeting provides a platform to tackle the challenges drug developers are experiencing.
Who is experiencing the same challenges? Who has the answers?
Learn and discuss with your peers, for instance, in:
• Epigenetic target identification, validation and exploitation
• On novel mechanisms for overcoming resistance to cancer therapies
• The use of epigenetic-based diagnostic tests for early and non-invasive cancer detection
• Using epigenetic drugs to target solid tumours
• Moving beyond cancer to investigate drug development in other disease areas
Innovative biotechs such as Epizyme, Constellation Pharmaceuticals and Chroma Therapeutics are pioneering the development of epigenetic drug products. There is a genuine buzz and large established pharma companies are investing in their own epigenetic research programs. Companies like Novartis, Pfizer, GSK, Eli Lilly, Genentech, Roche, Takeda, Merck and Sanofi Aventis are all active in this area.
We're already working with many of them.
The World Epigenetics Summit is the world's first commercially focussed meeting dedicated to bringing together leading figures from commercial and academic research to share best practice, solution-focussed science and business development opportunities relating to epigenetic drug development.
Don't miss this unique opportunity to meet your peers, learn how to overcome the challenges, accelerate drug development and generate opportunities for your business. If you're looking for a global, commercial epigenetics meeting that deliver the fantastic speakers, commercially relevant content and superb networking opportunities, you've come to the right place.
What's next?
1. Download the agenda to see more detail on the topics for coverage.
2. Stay update by joining the LinkedIn community. Search "Epigenetics”
3. Something you want to share? Then let us know...
4. Don't waste time! If you're planning on joining us then get the best rates by securing your place now - Book online or call +1 212 537 5898.
Everyone recognizes the potential of drugs targeting epigenetic pathways. Including the large drug developers and innovative biotechs who are working with us to put together this meeting
Amidst so many excellent academic-focussed meetings we are offering a completely different epigenetic conference. We are bringing together the leading commercial players in this field offering you the opportunity to find out more about the research that until now has taken place behind closed doors. This meeting provides a platform to tackle the challenges drug developers are experiencing.
Who is experiencing the same challenges? Who has the answers?
Learn and discuss with your peers, for instance, in:
• Epigenetic target identification, validation and exploitation
• On novel mechanisms for overcoming resistance to cancer therapies
• The use of epigenetic-based diagnostic tests for early and non-invasive cancer detection
• Using epigenetic drugs to target solid tumours
• Moving beyond cancer to investigate drug development in other disease areas
Innovative biotechs such as Epizyme, Constellation Pharmaceuticals and Chroma Therapeutics are pioneering the development of epigenetic drug products. There is a genuine buzz and large established pharma companies are investing in their own epigenetic research programs. Companies like Novartis, Pfizer, GSK, Eli Lilly, Genentech, Roche, Takeda, Merck and Sanofi Aventis are all active in this area.
We're already working with many of them.
The World Epigenetics Summit is the world's first commercially focussed meeting dedicated to bringing together leading figures from commercial and academic research to share best practice, solution-focussed science and business development opportunities relating to epigenetic drug development.
Don't miss this unique opportunity to meet your peers, learn how to overcome the challenges, accelerate drug development and generate opportunities for your business. If you're looking for a global, commercial epigenetics meeting that deliver the fantastic speakers, commercially relevant content and superb networking opportunities, you've come to the right place.
What's next?
1. Download the agenda to see more detail on the topics for coverage.
2. Stay update by joining the LinkedIn community. Search "Epigenetics”
3. Something you want to share? Then let us know...
4. Don't waste time! If you're planning on joining us then get the best rates by securing your place now - Book online or call +1 212 537 5898.
